4//SEC Filing
CATHERS BRIAN EDWIN 4
Accession 0000899243-20-007086
CIK 0001629137other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:48 PM ET
Size
9.4 KB
Accession
0000899243-20-007086
Insider Transaction Report
Form 4
CATHERS BRIAN EDWIN
See Remarks
Transactions
- Tax Payment
Common Stock
2020-03-01$63.96/sh−2,594$165,912→ 5,179 total - Exercise/Conversion
Common Stock
2020-03-01+7,500→ 7,773 total - Exercise/Conversion
Restricted Stock Units
2020-03-01−7,500→ 22,500 total→ Common Stock (7,500 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 7,500 shares of Common Stock underlying the Reporting Person's RSUs.
- [F3]The shares of Common Stock underlying the RSUs vested with respect to 1/4th of the shares on March 1, 2020 and thereafter 1/6th of the remaining underlying shares shall vest in semi-annual installments over 3 years from March 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
Documents
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001769127
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 8:48 PM ET
- Size
- 9.4 KB